{"id":"doi:10.1038/s41568-019-0116-x","kind":"review","title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","authors":["Jonathan J. Havel","Diego Chowell","Timothy An-thy Chan"],"author_count":3,"year":2019,"published":"2019-02-12","venue":"Nature reviews. Cancer","cited_by":2285,"doi":"10.1038/s41568-019-0116-x","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41568-019-0116-x","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41568-019-0116-x","updated":null,"pmid":"30755690","pmcid":null,"openalex_id":"W2914335731","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}